Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Head & Neck 1CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 52Prostatic Neoplasms 23Lung Neoplasms 17Breast Neoplasms 17Squamous Cell Carcinoma of Head and Neck 14Stomach Neoplasms 10Neoplasms 9Parkinson Disease 4, Autosomal Dominant Lewy Body 8Urinary Bladder Neoplasms 6Neoplasm Metastasis 6Head and Neck Neoplasms 6Carcinoma, Transitional Cell 6Triple Negative Breast Neoplasms 5Non-Muscle Invasive Bladder Neoplasms 5Carcinoma, Squamous Cell 5Prostatic Neoplasms, Castration-Resistant 4Ovarian Neoplasms 4Oropharyngeal Neoplasms 4Endometrial Neoplasms 4Small Cell Lung Carcinoma 3Salivary Gland Neoplasms 3Nasopharyngeal Carcinoma 3Laryngeal Neoplasms 3HER2-positive Breast Cancer 3Fallopian Tube Neoplasms 3Esophageal Squamous Cell Carcinoma 3Carcinoma 3Anatomic Stage I Breast Cancer AJCC v8 3Adenocarcinoma 3Vaccinia 2

Interventions

Fluorouracil 14pembrolizumab 13Paclitaxel 13Oxaliplatin 13Leucovorin 10Carboplatin 9Radiotherapy 8Capecitabine 8Trastuzumab 7Nivolumab 7Drug Therapy 7Cisplatin 7Radiation 6Esophagectomy 6Taxes 5Specimen Handling 5Irinotecan 4trastuzumab deruxtecan 3tislelizumab 3patritumab deruxtecan 3Surgical Procedures, Operative 3Radiotherapy, Intensity-Modulated 3Immunotherapy 3Blood Specimen Collection 3zanidatamab 2ulixertinib 2trastuzumab biosimilar HLX02 2relatlimab 2durvalumab 2atezolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Esophageal Neoplasms × Docetaxel × 90 days × Clear all
NCT05094336 2026-05-28

MTAPESTRY 101

Amgen

Phase 1/2 Active not recruiting
329 enrolled
CNSGastrointestinalHead & NeckThoracic

Squamous Cell Carcinoma of Head and Neck, Biliary Tract Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Glioma, Stomach Neoplasms

NCT06123338 2026-05-28

A Study of Pembrolizumab With Trastuzumab and Chemotherapy in People With Esophagogastric Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
49 enrolled
Gastrointestinal

Esophageal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡